Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Hamburg Cancer Registry, Ministry of Science, Research, Equality and Districts, Free and Hanseatic City of Hamburg, Süderstraße 30, 20097, Hamburg, Germany.
Blood Cancer J. 2024 Oct 11;14(1):174. doi: 10.1038/s41408-024-01158-9.
The prognostic influence of socioeconomic status (SES) on the survival of diffuse large B-cell lymphoma (DLBCL) patients remains controversial. This observational study examines the potential impact of regional SES inequalities on overall survival (OS) among DLBCL patients in Germany. We analyzed data from the German nationwide population-based dataset spanning 2004-2019 sourced from the German Center for Cancer Registry Data (n = 49,465). The primary objective was to assess the 5-year OS among patients with low SES compared to those living in middle and high SES areas. SES was grouped according to quintiles of the German Index of Socioeconomic Deprivation, which summarized nine indicators covering aspects of regional education, employment, and income. DLBCL patients in low SES areas had significantly impaired 5-year OS compared to those in middle and high SES regions (59.2% vs. 61.8% vs. 64.1%, p < 0.0001). Yet, additionally accounting for regional premature mortality removed the impact of SES on survival (Hazard Ratio 0.94, 95% CI 0.87-1.01). Our findings indicate that the prognostic impact of socioeconomic deprivation on long-term survival is not due to variations in diagnosis and treatment of DLBCL itself but rather a higher comorbidity burden.
社会经济地位(SES)对弥漫性大 B 细胞淋巴瘤(DLBCL)患者生存的预后影响仍存在争议。本观察性研究旨在探讨德国 SES 地区不平等对 DLBCL 患者总生存(OS)的潜在影响。我们分析了 2004 年至 2019 年德国全国基于人群的癌症登记数据中心(n=49465)的数据集。主要目的是评估 SES 较低患者与 SES 中高地区患者的 5 年 OS。SES 根据德国社会经济剥夺指数的五分位数进行分组,该指数综合了九个指标,涵盖了区域教育、就业和收入等方面。SES 较低地区的 DLBCL 患者的 5 年 OS 明显低于 SES 中高地区(59.2% vs. 61.8% vs. 64.1%,p<0.0001)。然而,进一步考虑区域过早死亡率后,SES 对生存的影响消失(风险比 0.94,95%CI 0.87-1.01)。我们的研究结果表明,社会经济剥夺对长期生存的预后影响不是由于 DLBCL 本身的诊断和治疗差异所致,而是由于更高的合并症负担。